Literature DB >> 9630560

Highly conserved amino-acid sequence between murine STAT3 and a revised human STAT3 sequence.

L D Pietra1, A Bressan, A R Pezzotti, O Serlupi-Crescenzi.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is an important mediator of cytokine signaling, whose cDNA and protein sequences have been fully characterized. We sequenced the whole human STAT3 cDNA isolated from HepG2 cells. The new sequence determined contains 43 nucleotide changes overall, corresponding to six modifications at the amino-acid level. The revised amino-acid sequence of human STAT3 is now completely identical to the mouse sequence, except for a single amino-acid change at position 760. Thus STAT3 now results as one of the most evolutionarily conserved among known proteins. By using specific RT-PCR we could discriminate between the original sequence and the new variant. Amplification of regions within the src-homology domain 2 (SH2) of STAT3, from the RNAs of 11 different tissues or cells, revealed only the expression of the new SH2 variant. Besides, only this SH2 variant was amplified from human genomic DNA. We conclude that the new sequence we have determined in this study represents a revised sequence of hSTAT3 or, less likely, a new predominant allele. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630560     DOI: 10.1016/s0378-1119(98)00185-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity.

Authors:  Zhou Zhou; Francisca C Gushiken; Doug Bolgiano; Breia J Salsbery; Niloufar Aghakasiri; Naijie Jing; Xiaoping Wu; K Vinod Vijayan; Rolando E Rumbaut; Roberto Adachi; Jose A Lopez; Jing-Fei Dong
Journal:  Circulation       Date:  2012-12-24       Impact factor: 29.690

Review 2.  Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy.

Authors:  Inès Dufait; Els Van Valckenborgh; Eline Menu; David Escors; Mark De Ridder; Karine Breckpot
Journal:  Oncotarget       Date:  2016-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.